Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top

Journal of Diabetes & Metabolic Disorders

2012 - 2024
Volumes
19
Issues
Chevron right icon
Issue 1/2024
Latest issue

Journal of Diabetes & Metabolic Disorders OnlineFirst articles

In vivo anti-diabetic and anti-lipidemic evaluations of an excellent synthetic α-glucosidase inhibitor with dihydropyrano[3,2-c]quinoline skeleton

Evaluating the prevalence and risk factors of sarcopenia in elderly patients with type 2 diabetes mellitus in a Chinese hospital setting

Allele frequency of genetic variations related to the UGT1A1 gene-drug pair in a group of Iranian population

  • Research article

Exploring the key role of DNA methylation as an epigenetic modulator in oxidative stress related islet cell injury in patients with type 2 diabetes mellitus: a review

Cardiometabolic risk factors trend in Iranian adults with hypertension over 15 years: findings of nationwide steps of 2007–2021

Deep learning based binary classification of diabetic retinopathy images using transfer learning approach

ECG–gated retinal vessel calibre as a novel measure of aberrant pulsatile retinal flow in diabetes mellitus: a cross-sectional study

Investigating the interaction between major dietary patterns and psychological disorders in association with sleep quality and quantity among Iranian adults: YaHS-TAMYZ study

A new glucose monitoring system for the intermittent monitoring of interstitial glucose values in patients with diabetes mellitus

Sex disparity in the burden of NCDs and its four main subgroups in Iran 1990–2019: a systematic analysis from the global burden of disease study 2019

  • Research article

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

About this journal

Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of diabetes and endocrinology, and provides a forum of debate of the highest quality on these issues.

Journal of Diabetes & Metabolic Disorders is the official journal of the Endocrinology and Metabolism Research Institute, published on behalf of Tehran University of Medical Sciences.

Metadata
Title
Journal of Diabetes & Metabolic Disorders
Coverage
Volume 11/2012 - Volume 23/2024
Publisher
Springer International Publishing
Electronic ISSN
2251-6581
Journal ID
40200

2024 ESC Congress

Noise pollution dangerous for heart health

Two studies underscore the adverse impact of noise pollution on the risk for and prognosis after myocardial infarction.

Read more

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits